Fridays’ current NAD+ product page describes a daily nasal spray and displays a $259 price. That is the offer reviewed here. Although the company’s broader safety materials mention injectable NAD+, those materials alone do not establish that the spray product page sells an injection kit.
We checked the public offer on September 19, 2026. We did not complete an intake or make a purchase. This review is grouped with nasal-spray alternatives so readers searching specifically for injections can distinguish the actual advertised format before comparing prices or starting a consultation.
Treat the reviewed Fridays offer as a nasal spray. Confirm the bottle, supply period, included care, and renewal terms before comparing its $259 figure with other formats.
The current product description is a spray
The Fridays NAD+ page identifies nasal administration in its product overview and explanation. Some surrounding labels are generic, which makes the full order description important. Ask the care team to confirm the preparation and route on the prescription rather than relying on a brief tab label.
Our injection-versus-spray guide explains why the formats should be compared separately. A spray may avoid needles, but convenience does not establish equal absorption, safety, or clinical benefit. If a different formulation is offered after intake, review its own instructions, price, and evidence rather than treating it as an automatic substitute.
What to ask about the $259 figure
The public page displays $259, but that number does not by itself settle the bottle size, usable duration, included clinical services, or renewal schedule. Obtain an itemized quote for the exact product you would receive. We do not turn the displayed figure into an assumed monthly subscription without those details.
Ask whether an existing Fridays membership or program changes the price and whether a new consultation is required. The NAD+ cost guide helps separate a medication charge from a membership, visit fee, or promotional offer. A clearly displayed number is helpful, but it must be connected to a defined purchase.
Match the safety information to the actual preparation
A general medication library can contain information for several routes. The directions that accompany your prescribed spray should identify its formulation, storage, labeled usable period, and the contact for questions. Do not adapt instructions for an injection to a nasal product or assume a shared ingredient name makes them interchangeable.
Ask the dispensing pharmacy to explain the device and label if anything is unclear. A spray still involves medication handling and prescription-specific directions. Our pharmacy verification guide can help you identify the facility responsible for the preparation rather than relying entirely on the service brand.
Distinguish customer experience from medical outcomes
Fridays’ page notes that some reported results reflect patient experiences rather than public clinical studies, and it distinguishes fulfillment performance from clinical outcomes. That distinction matters. An order arriving successfully does not demonstrate that a medication improved a symptom, and a positive customer story does not establish cause and effect.
Read the NAD+ evidence review and ask what research is relevant to the prescribed nasal preparation. Discuss a realistic goal and a point for reassessment. A convenient format or supportive online community should not replace an evaluation of persistent fatigue, cognitive concerns, or another reason for seeking care.
Compare Fridays with the right alternatives
The Midi Health review examines another nasal-spray offering, while GobyMeds and Joi + Blokes describe multiple formats. Compare the specific spray’s quantity, price, included care, and recurring terms, rather than mixing nasal products and injection kits in a cheapest-provider list.
For readers still considering injections, our CoreAge Rx review covers the featured commercial partner and a different treatment route. Fridays adds a useful alternative to the directory, provided the format remains clear. The next step is a confirmed prescription and complete quote, not an assumption based on a generic NAD+ label.
Follow the source
References & further reading
- Fridays — NAD+ nasal-spray product page
Checked September 19, 2026. Reviewed offer is a nasal spray. Generic injection safety material does not establish an injection-kit purchase.
- FDA — compounding questions and answers
Compounded drugs are not FDA-approved or reviewed before marketing for safety, effectiveness, or quality.
- FDA — ingredients suitable for sterile compounding
Reports NAD+ injectable adverse events and ingredient-quality concerns.
- Grant et al. (2019) — human NAD+ infusion pilot
Small IV metabolism study; does not establish benefits of home injections.